Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy
Clinical trial NCT02742090 · TERMINATED
Trial details
- NCT number
- NCT02742090
- Sponsor
- TG Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-21
- Primary completion
- 2021-06-10
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.